openPR Logo
Press release

Next-Gen Clinical Decision Support Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity

11-17-2025 01:41 PM CET | Health & Medicine

Press release from: MarketGenics India Pvt. Ltd.

Next-Gen Clinical Decision Support Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity

Next-Gen Clinical Decision Support Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity

A significant study discovering the market avenues on, "Next-Gen Clinical Decision Support Market Size, Share & Trends Analysis Report by Component (Software, Hardware, Services), Deployment Mode, Therapeutic Area, Technology, Interoperability, Data Source, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2026-2035" A holistic view of the market pathways in the next-gen clinical decision support market underscores revenue acceleration through three key levers scalable product line extensions, high‐maturity strategic partnerships.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Next-Gen Clinical Decision Support Market Research Report: https://marketgenics.co/press-releases/next-gen-clinical-decision-support-market-94010

Global Next-Gen Clinical Decision Support Market Forecast 2035:

According to the report, the global next-gen clinical decision support market is projected to expand from USD 1.7 billion in 2025 to USD 7.6 billion by 2035, registering a CAGR of 16.2%, the highest during the forecast period. The next-gen clinical decision support market is growing quickly due to the increased prevalence of chronic and complex conditions, clinical error reduction demands, and to provide high-quality, evidence-based care. Advanced CDSS systems take advantage of AI, machine learning and predictive analytics to deliver real-time and patient-specific insights, automated alerts, and workflow guidance.

The incorporation of the EHR/EMR systems, medical imaging, genomics, and wearable devices allows personalized and timely decision-making. The use of cloud platforms, mobile platforms and ambient intelligence further improves scalability, point of care access and operational efficiency. Strategic partnerships between vending vendors of CDSS, artificial intelligence creators, EHR vendors, and healthcare organizations enhance innovation, interoperability, and market penetrations.

Such emerging trends as real-time multi-source data integration, AI-based predictive analytics, and the move towards telehealth and remote monitoring can help address clinical outcomes. Altogether, the market is ready to be expanded successfully due to the investment in next-gen CDSS technologies, regulatory incentives, and their increasing use in healthcare environments.

"Key Driver, Restraint, and Growth Opportunity Shaping the Global Next-Gen Clinical Decision Support Market"

The rising investments and strategic partnerships of technology vendors, AI developers, and healthcare organizations are transforming the next-generation CDSS solutions faster. These collaborations will result in accelerated innovation by leveraging artificial intelligence, cloud infrastructure, and clinical workflows, improving the experience of interoperability with EHRs and other sources of data, and scalable, real-time decision support, which in turn will promote adoption and the growth of the next-gen clinical decision support market.

The concerns on data privacy, security, and regulatory compliance are limiting the next-gen clinical decision support market. CDSS platforms can contain sensitive patient health data and therefore are prone to breaches and cyberattacks. The combination of rules like HIPAA, GDPR, and other regional data protection regulations makes the work of the healthcare provider and vendor even more complicated. The operational costs are higher and the uptake of the advanced CDSS solutions are hindered by the need to have strong security measures, encryption, access controls, and continuous compliance monitoring.

The market is characterized by a large growth potential in the adoption of cloud-based and mobile CDSS platforms. In March 2025, Wolters Kluwer Health collaborated with Microsoft and other technology vendors to incorporate its CDSS content into cloud-based, ambient processes, such as voice, mobile, and device-based. This future generation solution will allow clinicians to reach evidence-based advice anytime, anywhere, improve the efficiency of workflow, accuracy of decisions, and accessibility of point-of-care, and will no longer be limited to desktop-based delivery of CDSS solutions.

To know more about the Next-Gen Clinical Decision Support Market - Download our Sample Report: https://marketgenics.co/download-report-sample/next-gen-clinical-decision-support-market-94010

Expansion of Global Next-Gen Clinical Decision Support Market

"Innovation, and public funding propel the global Next-Gen Clinical Decision Support market expansion"

The next-gen clinical decision support market is experiencing tremendous growth all over the world due to the ongoing technological advancement, incorporation of new sophisticated AI and analytics, and the growing need to have accurate and real-time clinical decisions. An example is that GuidelineX presented its AI-based CDSS at the HIMSS APAC, where it integrated with hospital information systems in both inpatient and outpatient care. The platform provides real-time and evidence-based recommendations, with high levels of clinician adoption and better patient outcomes, such as a decrease in hospital-associated venous thromboembolism (HA-VTE) and the earlier diagnosis of acute kidney injury (AKI).

Government policies and insurance incentives are essential in the process of enhancing the implementation of next-gen CDSS. Regulators and payers can promote the use of advanced decision-support tools by healthcare providers by providing them with financial reimbursement, grants, and value-based care incentives. The centres for Medicare and Medicaid Services (CMS) provided Viz.ai with a national payment rate of Medicare of 128.90 in 2025 regarding its AI-based ECG analysis. Such a reimbursement would allow hospitals to implement Viz HCM, an AI-based cardiomyopathy and other cardiac malformies detector that helps provide early diagnosis, evidence-based decision-making, and incorporate AI technologies into everyday cardiovascular practice.

Regional Analysis of Global Next-Gen Clinical Decision Support Market

Next-gen clinical decision support market in North America is considered the most promising because the region enjoys highly developed healthcare infrastructure, a good regulatory framework that supports interoperability, a high rate of EHR adoption, and adoption of AI and analytics into clinical processes are rapidly evolving to improve decision-making and patient outcomes.

Asia-Pacific will post the strongest growth in the next-gen clinical decision support market as a result of the rapid digitization of healthcare systems and government spending on health IT infrastructure and the rising use of cloud-based and mobile health platforms. The growing number of patients, the growing chronic disease rates, and the growing interest in the quality of care and efficiency of care delivery are creating the demand of smart, data driven clinical tools. Moreover, there is increasing cooperation among local hospitals, research centers, and tech companies which encourages innovation, and the big-scale implementation of the sophisticated CDS solutions to the new markets becomes possible.

Prominent players operating in the global next-gen clinical decision support market are Allscripts Healthcare Solutions, Athenahealth, Epic Systems Corporation, GE Healthcare, Health Catalyst, IBM Corporation, Infermedica, Isabel Healthcare, McKesson Corporation, Meditech, NextGen Healthcare, Oracle Health, Philips Healthcare, Siemens Healthineers, VisualDx, Wolters Kluwer Health, Zebra Medical Vision, Zynx Health (Hearst Health), and Other Key Players.

Buy Now: https://marketgenics.co/buy/next-gen-clinical-decision-support-market-94010

The global next-gen clinical decision support market has been segmented as follows:

Global Next-Gen Clinical Decision Support Market Analysis, By Component

Software

Standalone Software

Integrated Software

Hardware

Servers

Storage Devices

Networking Equipment

Others

Services

Implementation Services

Training & Education

Support & Maintenance

Consulting Services

Global Next-Gen Clinical Decision Support Market Analysis, By Deployment Mode

On-Premises

Enterprise-Level Deployment

Department-Level Deployment

Cloud-Based

Global Next-Gen Clinical Decision Support Market Analysis, By Therapeutic Area

Cardiology

Oncology

Neurology

Orthopedics

Gastroenterology

Infectious Diseases

Pediatrics

Others

Global Next-Gen Clinical Decision Support Market Analysis, By Technology

Predictive Analytics

Big Data Analytics

Rule-Based Systems

Clinical Guidelines Integration

Evidence-Based Medicine Tools

Artificial Intelligence (AI)

Others

Global Next-Gen Clinical Decision Support Market Analysis, By Interoperability

Integrated with EHR/EMR

Integrated with Laboratory Information Systems (LIS)

Integrated with Radiology Information Systems (RIS)

Integrated with Pharmacy Management Systems

Standalone Systems

FHIR-Enabled Systems

Others

Global Next-Gen Clinical Decision Support Market Analysis, By Data Source

Structured Data

Electronic Health Records

Laboratory Results

Imaging Reports

Others

Unstructured Data

Clinical Notes

Medical Literature

Patient-Generated Data

Others

Real-Time Data Feeds

Global Next-Gen Clinical Decision Support Market Analysis, By End-users

Healthcare Providers

Diagnosis Assistance

Treatment Planning

Medication Management

Clinical Documentation

Patient Monitoring

Others

Hospitals

Inpatient Care Management

ICU Decision Support

Emergency Department Support

Surgical Decision Support

Antimicrobial Stewardship

Readmission Risk Prediction

Others

Ambulatory Care Centers

Outpatient Diagnosis

Chronic Disease Management

Preventive Care Recommendations

Medication Reconciliation

Follow-up Care Optimization

Others

Diagnostic Centers

Imaging Interpretation Support

Laboratory Result Analysis

Pathology Decision Support

Multi-Modal Diagnostic Integration

Others

Pharmaceutical & Biotechnology Companies

Drug Development Support

Clinical Trial Design

Pharmacovigilance

Real-World Evidence Analysis

Drug Repurposing Research

Others

Research & Academic Institutions

Payers (Insurance Companies)

Long-Term Care Facilities

Home Healthcare

Other End-users

Global Next-Gen Clinical Decision Support Market Analysis, By Region

North America

Europe

Asia Pacific

Middle East

Africa

South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.

We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.

Contact:

Mr. Debashish Roy

MarketGenics India Pvt. Ltd.

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next-Gen Clinical Decision Support Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity here

News-ID: 4273896 • Views:

More Releases from MarketGenics India Pvt. Ltd.

Biosimilars Market to Quadruple by 2035, Driven by 13.4% CAGR & Global Demand Surge
Biosimilars Market to Quadruple by 2035, Driven by 13.4% CAGR & Global Demand Su …
The Biosimilars Market is undergoing unprecedented expansion, driven by rising healthcare costs, the patent expiry of blockbuster biologics, and shifting preferences of healthcare systems toward cost-effective treatment alternatives. The market, valued at USD 31.6 billion in 2025, is projected to reach USD 125.9 billion by 2035, growing at an impressive CAGR of 13.4%. As chronic diseases continue to rise globally-especially cancer, autoimmune disorders, and diabetes-the demand for affordable biologic therapies
Telemedicine Market to Reach USD 279.9 Billion by 2035, Riding on a Strong 12.3% CAGR
Telemedicine Market to Reach USD 279.9 Billion by 2035, Riding on a Strong 12.3% …
The Telemedicine Market has rapidly evolved into one of the most transformative pillars of modern healthcare, reshaping the way patients connect with physicians, receive treatment, and manage chronic diseases. Valued at USD 78.1 billion in 2025, the market is expected to expand significantly, reaching USD 279.9 billion by 2035, at a robust CAGR of 12.3%. This long-term growth is propelled by the rising demand for remote healthcare access, the global
Remote Patient Monitoring Market to Hit USD 88.3 Billion by 2035, Driven by AI-Enabled Healthcare Solutions
Remote Patient Monitoring Market to Hit USD 88.3 Billion by 2035, Driven by AI-E …
The Remote Patient Monitoring Market is entering a high-growth era as the world embraces technology-enabled care, decentralized healthcare models, and continuous digital monitoring for chronic diseases. Valued at USD 26.1 billion in 2025, the market is forecast to expand at an impressive CAGR of 11.7% through 2035, reaching nearly USD 88.3 billion. This growth reflects a major transformation in how healthcare is delivered-moving from episodic, hospital-centric care to continuous, home-based,
Contrast Media Market to Reach USD 14.1 Billion by 2035, Driven by Advancements in Diagnostic Imaging
Contrast Media Market to Reach USD 14.1 Billion by 2035, Driven by Advancements …
The Contrast Media Market is undergoing a transformative phase as advancements in medical imaging, rising chronic disease prevalence, and the global shift toward precision diagnostics drive strong, sustained growth. Valued at USD 6.6 billion in 2025, the market is projected to reach USD 14.1 billion by 2035, registering an impressive CAGR of 7.2%. This double-digit expansion is backed by increasing reliance on CT, MRI, and ultrasound imaging for early diagnosis

All 5 Releases


More Releases for Support

Ways to Call Canon Printer Support or Customer Service: by Phone , Chat, and Ema …
Contact Us - Canon U.S.A. Inc Find the Canon Printer support number 1-888-272-8868 USA or Canon Customer Service Number 1-888-272-8868 US for your Canon Printer product by group or register your product online. Get access to drivers, manuals, videos, community and more resources from Canon U.S.A. Drivers & Downloads Drivers & Downloads - Canon Printer Support 1-888-272-8868 | Canon U.S.A., Inc. Software & Drivers Software & Drivers - Canon Customer Service
Ways to Call QuickBooks Desktop Support or Customer Service :by Phone , Chat, an …
The main QuickBooks customer service number is 1-844-893-6804, where you can reach a live representative 24/7. Whether you're dealing with payroll setup, login issues, subscription billing, or technical errors, speaking with a real person can make all the difference. You can also use QuickBooks live chat or email support for added flexibility. This guide walks you through how to contact QuickBooks support efficiently-plus helpful tips to reduce wait times and
HappyPulse Blood Support
If you're here, you're probably looking for ways to boost your overall health, manage blood sugar levels, and promote better circulation. That's where HappyPulse Blood Support comes into play. This all-natural supplement is gaining popularity for helping support healthy blood function and circulation, making it a top choice for people looking to optimize their health naturally. Here, we'll take a closer look at what HappyPulse Blood Support is? ‍ Product Name -
Clinical Decision Support App Market Clinical Decision Support App Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Clinical Decision Support App Market Size, Share & Trends Analysis Report By Delivery Platform (Web-Based CDS Apps, Mobile-Based CDS Apps), By End User (Hospitals And Clinics, Ambulatory Care Centres, Long-Term Care Facilities), By Application (Diagnostic Support, Treatment Decision Support, Drug Interactions And Safety), By Region, And By Segment Forecasts, 2024-2031" According to the latest research by InsightAce
Global Facilities Support Services Market | Global Facilities Support Services I …
The facilities support services market comprises of sales of facilities support services and connected goods by entities (organizations, sole traders and partnerships) that deliver operating staff to accomplish a combination of support services inside a client`s facilities. Examples of facilities support services comprise janitorial, maintenance, trash disposal, guard and security, mail routing, reception, laundry, and connected services to support operations within facilities. According to the analysis, ‘Facilities Support Services Global
Nutrition Support Services Market May Set New Growth Story | Cleveland Clinic, A …
A new business intelligence report released by HTF MI with title "Global Nutrition Support Services Market Size, Status and Forecast 2019-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Nutrition Support Services Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both